Form 8-K - Current report:
SEC Accession No. 0001193125-25-129522
Filing Date
2025-05-28
Accepted
2025-05-28 16:34:31
Documents
12
Period of Report
2025-05-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d51891d8k.htm   iXBRL 8-K 34377
  Complete submission text file 0001193125-25-129522.txt   144608

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aclx-20250528.xsd EX-101.SCH 2839
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20250528_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20250528_pre.xml EX-101.PRE 10805
14 EXTRACTED XBRL INSTANCE DOCUMENT d51891d8k_htm.xml XML 3494
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 25995886
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)